Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea

Impacto

Downloads

Downloads per month over past year

Díaz Valle, David and Burgos Blasco, Bárbara and Rego Lorca, Daniela and Puebla Garcia, Virginia and Pérez García, Pilar and Benítez del Castillo, José Manuel and Herrero Vanrell, Rocío and Vicario de la Torre, Marta and Gegúndez Fernández, José Antonio (2021) Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea. Acta Ophthalmologica . ISSN 1755-375X (In Press)

[thumbnail of Postprint] PDF (Postprint)
Restringido a Repository staff only hasta 18 August 2022.

508kB

Official URL: https://doi.org/10.1111/aos.14997




Abstract

Purpose: To investigate the effect of topical insulin on epithelization in persistent epithelial defects (PED) refractory to usual treatment compared to autologous serum.
Design: Retrospective, consecutive case–control series.
Methods: The charts of 61 consecutive patients with PED treated with topical insulin (case group) and 23 treated with autologous serum (control group) were reviewed. Primary efficacy end points were the percentage of patients in which epithelization was achieved, as well as the rate and time until epithelization. Secondary efficacy point was need for amniotic membrane transplantation (AMT) or other surgeries.
Results: Mean time between PED diagnosis and start of topical insulin was 22.7 � 18.5 days (range 13–115) and the mean area was 14.8 � 16.2 mm2 (range 1.1–70.6). In the control group, mean time was 27.9 � 16.8 days, mean epithelial defect area being 18.6 � 15.0 mm2 (range 1.7–52.9). No differences in baseline characteristics were found between groups (p > 0.05). Epithelization
was achieved in 51 patients (84%) on insulin and 11 patients (48%) on autologous serum (p = 0.002). In those patients, mean time until reepithelization was 32.6 � 28.3 days (range 4–124) in the insulin group and 82.6 � 82.4 days (range 13–231) in the autologous serum group (p = 0.011). The need for AMT was significantly lower in the insulin group (p = 0.005). PED recurrence was higher in patients treated on autologous serum (43%) compared with insulin (11%) (p = 0.002).
Conclusions: Topical insulin is an effective treatment and safely promotes healing of PED. In our series, topical insulin presented better epithelization outcomes than autologous serum and could thus be considered as a first-line treatment.


Item Type:Article
Additional Information:

Received on June 1st, 2021 / Accepted on August 4th, 2021 / First published: 18 August 2021.
* La URL del DOI da error.

Uncontrolled Keywords:Autologous serum; Corneal epithelial defect; Insulin
Subjects:Medical sciences > Medicine > Pharmacology
Medical sciences > Medicine > Ophtalmology
ID Code:67815
Deposited On:20 Dec 2021 14:11
Last Modified:20 Dec 2021 15:12

Origin of downloads

Repository Staff Only: item control page